39 results
8-K
EX-1.1
TRML
Tourmaline Bio Inc
26 Jan 24
Other Events
4:12pm
and, if due and payable, any related or similar assessment, fine or penalty levied against any of them except as may be being contested in good faith
424B5
TRML
Tourmaline Bio Inc
26 Jan 24
Prospectus supplement for primary offering
4:08pm
; and
an exemption from the auditor attestation requirement in the assessment of our internal control over financial reporting.
We may take advantage
424B5
2v2u7z57g5l8t8ol0
24 Jan 24
Prospectus supplement for primary offering
9:20pm
8-K
EX-99.1
ecygj2 30xhywy
24 Jan 24
Results of Operations and Financial Condition
5:10pm
424B3
5uqazvyxavu m9r
15 Sep 23
Prospectus supplement
6:31am
425
uqhcelzbikc08kg8i
13 Sep 23
Business combination disclosure
9:14am
8-K
EX-99.1
d2cra 9q1j9yux
13 Sep 23
Regulation FD Disclosure
9:13am
S-4/A
7vwze9 nrti
25 Aug 23
Registration of securities issued in business combination transactions (amended)
4:34pm
S-4
9hccvrm7t
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
425
dznp5pnhvpcz
22 Jun 23
Business combination disclosure
9:12am
8-K
EX-2.1
8wczmcd rx1
22 Jun 23
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
9:10am